Cyient DLM Limited — PPTs, 22-01-2026: Investor Presentation

Cyient DLM's Q3 FY26 results show revenue at ₹303.3 Cr, down 31.7% YoY, primarily due to a large order completion in the previous year. Despite this, normalized EBITDA margin improved significantly to 10.2% (+207 bps YoY), reflecting strong operational resilience and better mix. Normalized PAT stood at ₹13.8 Cr, down 18.6% YoY. The order backlog grew 1.9% YoY to ₹2,349.4 Cr, fueled by a strong order intake of ₹387.1 Cr this quarter.

Aerospace segment showed a 13% YoY growth, while Defense saw an 86% degrowth. Industrial and Med-Tech segments achieved strong growth.

Strategically, the company is strengthening its Go-to-Market efforts, investing in operational excellence with automation, and exploring inorganic expansion in Europe and enhancing its global Defense presence. They've also begun realizing revenue from B2S initiatives and plan significant scale-up. Recent wins include two new customers in Medical and Industrial sectors, alongside recognition for Electronic Hardware Exports. Management emphasizes strengthening the B2S team and continued focus on strategic growth areas.